Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats

H. Fébel, B. Szegedi, Szilvia Huszár

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The intestinal absorption of trivalent and hexavalent chromium (Cr) given orally (experiment I) or infused in the intestine (experiment II) was investigated in rats. The nonabsorbable form of chromium (51Cr2O3) and water-soluble and more absorbable Na251CrO4 (the hexavalent form of Cr) were compared. Total retention of chromium given orally ranged around 15 percent of the dose, regardless of the chromium compounds applied. The absorption rate of chromic oxide, which is considered a nonabsorbable compound, was 14.4 as a percentage of chromium intake. This result indicates that some loss of chromium has to be taken into account in metabolic trials made by the indicator method. In isolated rat intestine, from the injected Cr 2.5% of chromic oxide and 43.2% of sodium chromate were absorbed during an hour (experiment II). The absorbed chromium was transferred to the liver where the liver tissue retained 10.9% of chromic oxide and 51.1% of sodium chromate. Radioactivity of v. cava caudalis following intestinal injection of Na2CrO4 was thirtyfold greater than after Cr2O3 dosing. This phenomenon can be explained by the lower blood clearance of chromate. Different absorption rate of chromate depending on the route of administration could be due to the fact that the hexavalent form given orally was reduced to Cr3+ in the acidic environment of the stomach. When Na2CrO4 was infused directly in the intestine of rats, such reduction could not occur. This means that the acidic gastric juice might play a role in inhibiting the intestinal absorption of Na2CrO4 when this compound is given orally.

Original languageEnglish
Pages (from-to)203-209
Number of pages7
JournalActa Veterinaria Hungarica
Volume49
Issue number2
DOIs
Publication statusPublished - 2001

Fingerprint

Chromium
chromium
mouth
Intestines
rats
dosage
Chromates
chromic oxide
Intestinal Absorption
intestines
Chromium Compounds
intestinal absorption
Gastric Juice
Liver
sodium
Radioactivity
gastric juice
chromium hexavalent ion
Stomach
liver

Keywords

  • Absorption
  • Chromium
  • Excretion
  • Rats
  • Retention

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats. / Fébel, H.; Szegedi, B.; Huszár, Szilvia.

In: Acta Veterinaria Hungarica, Vol. 49, No. 2, 2001, p. 203-209.

Research output: Contribution to journalArticle

@article{31be34929d224295a08b4f2afc58076a,
title = "Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats",
abstract = "The intestinal absorption of trivalent and hexavalent chromium (Cr) given orally (experiment I) or infused in the intestine (experiment II) was investigated in rats. The nonabsorbable form of chromium (51Cr2O3) and water-soluble and more absorbable Na251CrO4 (the hexavalent form of Cr) were compared. Total retention of chromium given orally ranged around 15 percent of the dose, regardless of the chromium compounds applied. The absorption rate of chromic oxide, which is considered a nonabsorbable compound, was 14.4 as a percentage of chromium intake. This result indicates that some loss of chromium has to be taken into account in metabolic trials made by the indicator method. In isolated rat intestine, from the injected Cr 2.5{\%} of chromic oxide and 43.2{\%} of sodium chromate were absorbed during an hour (experiment II). The absorbed chromium was transferred to the liver where the liver tissue retained 10.9{\%} of chromic oxide and 51.1{\%} of sodium chromate. Radioactivity of v. cava caudalis following intestinal injection of Na2CrO4 was thirtyfold greater than after Cr2O3 dosing. This phenomenon can be explained by the lower blood clearance of chromate. Different absorption rate of chromate depending on the route of administration could be due to the fact that the hexavalent form given orally was reduced to Cr3+ in the acidic environment of the stomach. When Na2CrO4 was infused directly in the intestine of rats, such reduction could not occur. This means that the acidic gastric juice might play a role in inhibiting the intestinal absorption of Na2CrO4 when this compound is given orally.",
keywords = "Absorption, Chromium, Excretion, Rats, Retention",
author = "H. F{\'e}bel and B. Szegedi and Szilvia Husz{\'a}r",
year = "2001",
doi = "10.1556/AVet.49.2001.2.10",
language = "English",
volume = "49",
pages = "203--209",
journal = "Acta Veterinaria Hungarica",
issn = "0236-6290",
publisher = "Akademiai Kiado",
number = "2",

}

TY - JOUR

T1 - Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats

AU - Fébel, H.

AU - Szegedi, B.

AU - Huszár, Szilvia

PY - 2001

Y1 - 2001

N2 - The intestinal absorption of trivalent and hexavalent chromium (Cr) given orally (experiment I) or infused in the intestine (experiment II) was investigated in rats. The nonabsorbable form of chromium (51Cr2O3) and water-soluble and more absorbable Na251CrO4 (the hexavalent form of Cr) were compared. Total retention of chromium given orally ranged around 15 percent of the dose, regardless of the chromium compounds applied. The absorption rate of chromic oxide, which is considered a nonabsorbable compound, was 14.4 as a percentage of chromium intake. This result indicates that some loss of chromium has to be taken into account in metabolic trials made by the indicator method. In isolated rat intestine, from the injected Cr 2.5% of chromic oxide and 43.2% of sodium chromate were absorbed during an hour (experiment II). The absorbed chromium was transferred to the liver where the liver tissue retained 10.9% of chromic oxide and 51.1% of sodium chromate. Radioactivity of v. cava caudalis following intestinal injection of Na2CrO4 was thirtyfold greater than after Cr2O3 dosing. This phenomenon can be explained by the lower blood clearance of chromate. Different absorption rate of chromate depending on the route of administration could be due to the fact that the hexavalent form given orally was reduced to Cr3+ in the acidic environment of the stomach. When Na2CrO4 was infused directly in the intestine of rats, such reduction could not occur. This means that the acidic gastric juice might play a role in inhibiting the intestinal absorption of Na2CrO4 when this compound is given orally.

AB - The intestinal absorption of trivalent and hexavalent chromium (Cr) given orally (experiment I) or infused in the intestine (experiment II) was investigated in rats. The nonabsorbable form of chromium (51Cr2O3) and water-soluble and more absorbable Na251CrO4 (the hexavalent form of Cr) were compared. Total retention of chromium given orally ranged around 15 percent of the dose, regardless of the chromium compounds applied. The absorption rate of chromic oxide, which is considered a nonabsorbable compound, was 14.4 as a percentage of chromium intake. This result indicates that some loss of chromium has to be taken into account in metabolic trials made by the indicator method. In isolated rat intestine, from the injected Cr 2.5% of chromic oxide and 43.2% of sodium chromate were absorbed during an hour (experiment II). The absorbed chromium was transferred to the liver where the liver tissue retained 10.9% of chromic oxide and 51.1% of sodium chromate. Radioactivity of v. cava caudalis following intestinal injection of Na2CrO4 was thirtyfold greater than after Cr2O3 dosing. This phenomenon can be explained by the lower blood clearance of chromate. Different absorption rate of chromate depending on the route of administration could be due to the fact that the hexavalent form given orally was reduced to Cr3+ in the acidic environment of the stomach. When Na2CrO4 was infused directly in the intestine of rats, such reduction could not occur. This means that the acidic gastric juice might play a role in inhibiting the intestinal absorption of Na2CrO4 when this compound is given orally.

KW - Absorption

KW - Chromium

KW - Excretion

KW - Rats

KW - Retention

UR - http://www.scopus.com/inward/record.url?scp=0035235251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035235251&partnerID=8YFLogxK

U2 - 10.1556/AVet.49.2001.2.10

DO - 10.1556/AVet.49.2001.2.10

M3 - Article

C2 - 11402649

AN - SCOPUS:0035235251

VL - 49

SP - 203

EP - 209

JO - Acta Veterinaria Hungarica

JF - Acta Veterinaria Hungarica

SN - 0236-6290

IS - 2

ER -